Health Quality Ontario (HQO) Evidence Development and Standards team

Alternate name: 
L'équipe d'analyse des données et des normes de Qualité des services de santé Ontario (QSSO)
Country: 
Canada
World area: 
America, North
The Health Quality Ontario (HQO) Evidence Development and Standards team (formerly the Medical Advisory Secretariat), led by Dr. Leslie Levin, is a partnership of HQO staff and scientific collaborators. The clinical component of HQO’s evidence-based analyses consists of a systematic review of the published evidence on the safety, efficacy and effectiveness of the intervention. These reviews are conducted by HQO staff, including clinical epidemiologists, medical information officers, and medical editors. For interventions that are effective, the evidence-based analysis also includes an economic analysis, which consists of 1 or more of the following: a systematic review of the cost-effectiveness literature, a cost-effectiveness analysis, and/or a budget impact analysis. The cost-effectiveness analyses are conducted by health economists from the Toronto Health Economic and Technology Assessment (THETA) Collaborative and the Programs for Assessment of Technology in Health (PATH) Research Institute. HumanEra at the University Health Network undertakes reviews on topics related to human factors and safety. Occasionally the Centre for Health Economics and Policy Analysis (CHEPA) conducts systematic reviews of the qualitative literature to evaluate patient, health care provider, and caregiver experiences with the intervention under review.
URL: 
http://www.hqontario.ca/en/mas/mas.html
Publications: 
http://www.hqontario.ca/evidence/publications-and-ohtac-recommendations
Jobs at this agency: 
http://www.hqontario.ca/about-us/careers
References on the country: 

Journal Article

Battista RN, Côté B, Hodge MJ, Husereau D. Health technology assessment in Canada. Int J Technol Assess Health Care. 2009;25 Suppl 1:53-60. Abstract
DeJean D, Giacomini M, Schwartz L, Miller FA. Ethics in Canadian health technology assessment: a descriptive review. Int J Technol Assess Health Care. 2009;25(4):463-9. Abstract
Hailey DM. Health technology assessment in Canada: diversity and evolution. Med J Aust. 2007;187(5):286-8. Abstract
Lehoux P, Tailliez S, Denis J-, Hivon M. Redefining health technology assessment in Canada: diversification of products and contextualization of findings. Int J Technol Assess Health Care. 2004;20(3):325-36. Abstract
McDaid D. Co-ordinating health technology assessment in Canada: a European perspective. Health Policy. 2003;63(2):205-13. Abstract
Menon D, Topfer LA. Health technology assessment in Canada. A decade in review. Int J Technol Assess Health Care. 2000;16(3):896-902. Abstract
Menon D, Stafinski T. Health technology assessment in Canada: 20 years strong? Value Health. 2009;12 Suppl 2:S14-9.
Tarride J-, McCarron CE, Lim M, Bowen JM, Blackhouse G, Hopkins R, et al. Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand? Int J Technol Assess Health Care. 2008;24(4):437-44. Abstract
Xie F, Bowen JM, Sutherland SC, Burke N, Blackhouse G, Tarride J-, et al. Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective. Expert Rev Pharmacoecon Outcomes Res. 2011;11(5):513-21. Abstract

Web Article

Canada - GHO Country statistics. Vol 2014. Geneva: World Health Organisation (WHO); 2014. Abstract
Canada - OECD Countries. Vol 2014. Paris: Organisation for Economic Co-operation and Development (OECD); 2014.

Book

Marchildon GP. Canada: Health system review. Vol 15 (1). Sagan A, Thomson S, editors. Copenhagen: WHO Regional Office for Europe; 2013. Abstract

Report

Thomson S, Osborn R, Squires D, Jun M. International Profiles of Health Care Systems, 2012 Australia, Canada, Denmark, England, France, Germany, Iceland, Italy, Japan, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United States. New York: The Commonwealth Fund; 2012. Abstract